Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Surgical Science Sweden

34.74 SEK

+4.89 %

Less than 1K followers

SUS

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
+4.89 %
-57.89 %
-62.60 %
-76.27 %
-77.72 %
-76.30 %
-77.25 %
-59.13 %
+202.09 %

Surgical Science Sweden operates in the medical technology sector. The company develops VR simulators in surgery. The simulators consist of both hardware and software that are used in training and personal development for surgeons. The hardware simulates various surgical procedures, primarily used in keyhole surgery and endoscopy. The vision is to strengthen expertise in surgery and create conditions for better treatments. The headquarters are located in Gothenburg.

Read more
Market cap
1.77B SEK
Turnover
19.98M SEK
Revenue
884.09M
EBIT %
16.32 %
P/E
13.47
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
19/2
2026

Annual report '25

20/5
2026

Interim report Q1'26

21/5
2026

General meeting '26

All
Webcasts
Press releases
ShowingAll content types
Surgical Science Sweden, Capital Markets Day, CMD, 2025
Webcast12/8/2025, 1:00 PM

Surgical Science Sweden, Capital Markets Day, CMD, 2025

Surgical Science Sweden
Regulatory press release11/25/2025, 9:57 PM

Intuitive cancels the MoU and reverts to existing agreements. Surgical Science estimates that this will have a negative impact on license revenues of around SEK 60-90 million in 2026, compared to 2025.

Surgical Science Sweden
Regulatory press release11/25/2025, 9:57 PM

Intuitive säger upp MoU och går tillbaka till existerande avtal. Surgical Science uppskattar att detta kommer ha en negativ effekt på bolagets licensintäkter om 60-90 MSEK för 2026, jämfört med 2025.

Surgical Science Sweden

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release11/14/2025, 11:30 AM

Redeye: Surgical Science (Q3 review) - Soft margins and cash conversion

Surgical Science Sweden
Press release11/14/2025, 9:04 AM

Investor Studios: VD Tom Englund kommenterar rapporten i Market Update 11.00

Surgical Science Sweden
Surgical Science Sweden, Audiocast, Q3'25
Webcast11/13/2025, 10:00 AM

Surgical Science Sweden, Audiocast, Q3'25

Surgical Science Sweden
Regulatory press release11/13/2025, 6:30 AM

Interim report January–September 2025: Progress in the right direction

Surgical Science Sweden
Regulatory press release11/13/2025, 6:30 AM

Delårsrapport Januari–september 2025: Utveckling i rätt riktning

Surgical Science Sweden
Press release11/3/2025, 9:00 AM

Conference call regarding interim report Q3

Surgical Science Sweden
Press release11/3/2025, 9:00 AM

Telefonkonferens avseende delårsrapport Q3

Surgical Science Sweden
Press release10/20/2025, 11:45 AM

Invitation to Surgical Science’s Capital Markets Day 2025

Surgical Science Sweden
Press release10/20/2025, 11:45 AM

Inbjudan till Surgical Sciences Kapitalmarknadsdag 2025

Surgical Science Sweden
Press release10/1/2025, 9:20 AM

Valberedning i Surgical Science Sweden AB (publ)

Surgical Science Sweden
Press release10/1/2025, 9:20 AM

Nomination Committee of Surgical Science Sweden AB (publ)

Surgical Science Sweden
Press release8/22/2025, 8:44 AM

Redeye: Surgical Science Q2 2025 - Expect continued volatility

Surgical Science Sweden
Surgical Science Sweden, Audiocast, Q2'25
Webcast8/21/2025, 9:00 AM

Surgical Science Sweden, Audiocast, Q2'25

Surgical Science Sweden
Regulatory press release8/21/2025, 5:30 AM

Delårsrapport januari–juni 2025: Svag försäljning och stora valutaeffekter tynger resultatet

Surgical Science Sweden
Regulatory press release8/21/2025, 5:30 AM

Interim report January–June 2025: Weak sales and significant currency effects weighed on the result

Surgical Science Sweden
Press release8/11/2025, 8:00 AM

Telefonkonferens avseende delårsrapport Q2

Surgical Science Sweden
Press release8/11/2025, 8:00 AM

Conference call regarding interim report Q2

Surgical Science Sweden
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.